Dimethylbarbituric acid → Ethoxy-[4-(2-hydroxy-4-methyl-phenyl)-2-methyl-5,6,7,8-tetrahydro-benzo[4,5]thieno[2,3-b]pyridin-3-yl]-acetic acid ethyl ester
Reaction equation
[CH2:1]([O:3][C:4](=[O:34])[CH:5]([C:9]1[C:10]([C:23]2[CH:28]=[CH:27][C:26]([CH3:29])=[CH:25][C:24]=2[O:30]CC=C)=[C:11]2[C:18]3[CH2:19][CH2:20][CH2:21][CH2:22][C:17]=3[S:16][C:12]2=[N:13][C:14]=1[CH3:15])[O:6][CH2:7][CH3:8])[CH3:2].CN1C(=O)CC(=O)N(C)C1=O>ClCCl>[CH2:1]([O:3][C:4](=[O:34])[CH:5]([O:6][CH2:7][CH3:8])[C:9]1[C:10]([C:23]2[CH:28]=[CH:27][C:26]([CH3:29])=[CH:25][C:24]=2[OH:30])=[C:11]2[C:18]3[CH2:19][CH2:20][CH2:21][CH2:22][C:17]=3[S:16][C:12]2=[N:13][C:14]=1[CH3:15])[CH3:2]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a stirred solution of [4-(2-Allyloxy-4-methyl-phenyl)-2-methyl-5,6,7,8-tetrahydro-benzo[4,5]thieno[2,3-b]pyridin-3-yl]-ethoxy-acetic acid ethyl ester (22 mg, 46 μmols) in dichloromethane (3 mL) was added 1,3-dimethylbarbituric acid (38 mg, 240 μmols, 5 eq), and the reaction was evacuated and filled with nitrogen. Palladium tetrakis(triphenylphosphine) (1.2 mg, 2 mol %) was added and the reaction was heated to reflux for 16 hours. The reaction was concentrated in vacuo. The residue was purified using ISCO Companion with a Redisep silica gel 4 g cartridge and a gradient of heptane and ethyl acetate (0% to 40%). Fractions containing desired product were combined and concentrated in vacuo to give ethoxy-[4-(2-hydroxy-4-methyl-phenyl)-2-methyl-5,6,7,8-tetrahydro-benzo[4,5]thieno[2,3-b]pyridin-3-yl]-acetic acid ethyl ester as a pale yellow oil, 20 mg (95% yield). LC-MS (12 min acidic) 6.40 mins 58-69% pure by UV, ES+/APCI+ 440, ES−/APCI− 438; 6.66 mins 27-31% pure by UV, ES+/APCI+ 440, ES−/APCI− 438.
Workup
- customthe reaction was evacuated
- additionfilled with nitrogen
- additionPalladium tetrakis(triphenylphosphine) (1.2 mg, 2 mol %) was added
- temperaturethe reaction was heated
- temperatureto reflux for 16 hours
- concentrationThe reaction was concentrated in vacuo
- customThe residue was purified
- additionFractions containing desired product
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-4fe44091cf1e44898f419f82a233cfbf
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08809363B2
Reaction notes
Loading…